intravenous infusion Initial U.S. Approval: 1996
Irinotecan Injection is a topoisomerase inhibitor indicated for: • First-line therapy in combination with 5-fluorouracil and leucovorin for patients with metastatic carcinoma of the colon or rectum. • Patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial fluorouracil-based therapy.
Facts about Irinotecan Injection
Approval Date: 1996
Proprietary Name: On Request
Active Ingredient(s): Irinotecan Injection
Dosage Forms And Strengths: Available in three single-dose sizes: • 2 mL-fill vial containing 40 mg irinotecan hydrochloride injection • 5 mL-fill vial containing 100 mg irinotecan hydrochloride injection • 15 mL-fill vial containing 300 mg irinotecan hydrochloride injection
Company: Pfizer Inc
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
Access the best support services globally
If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import Irinotecan Injection” based on the information you provide.
Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.
MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398
Query For Irinotecan Injection
Approved accessible "Irinotecan Injection"
Irinotecan hydrochloride is approved to be used alone or with other drugs to treat: • Colorectal cancer that has metastasized (spread to other parts of the body), including metastatic cancer that has recurred (come back) or has not gotten better with other chemotherapy.
Irinotecan hydrochloride is also being studied in the treatment of other types of cancer. Irinotecan hydrochloride is also available in a different form called irinotecan hydrochloride liposome.
XELIRI ( Capecitabine (Xeloda) & Irinotecan Hydrochloride) is used to treat:
- Colorectal cancer that has metastasized (spread to other parts of the body).
- Esophageal cancer that is advanced or has metastasized.
- Gastric (stomach) cancer that is advanced or has metastasized.
This combination may also be used with other drugs or treatments or to treat other types of cancer.
How can 1 go about obtaining Irinotecan Injection?
If Irinotecan Injection are not yet approved or available in your area, you may request its price in India under a specific brand name through IPN. For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) / +91 9811 747 774 (Mr. Neeraj).
CAMPTOSAR (Irinotecan) Injection, intravenous infusion Initial U.S. Approval: 1996
Indian Pharma Network (IPN), New Delhi. India
Indian Pharma Network (IPN) is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry. Specialized in Oncology Products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act.
Branch Offices in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur.
Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Brazil | Saudi Arabia | South Africa
Indian Pharma Network
Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398